Sun Pharma Makes Massive $12 Billion Binding Offer for US Firm Organon
Sun Pharma fell 4% after a $12B bid for Organon, raising debt worries despite strong cash and ongoing deal talks.
/ 2 items
Sun Pharma fell 4% after a $12B bid for Organon, raising debt worries despite strong cash and ongoing deal talks.
Organon's (OGN) CEO Kevin Ali resigns following internal probe into Nexplanon birth-control implant sales practices. Company appoints interim chief and implements corrective measures.